| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/29/2007 | WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists |
| 03/29/2007 | WO2006060424A3 Inducible nitric oxide synthase dimerization inhibitors |
| 03/29/2007 | WO2005092066A8 Imidazole compounds |
| 03/29/2007 | US20070073052 Cyanoacrylic acid group containing benzo(thia/selena)diazole-based dyes used in a dye-sensitized solar cell; performance can be improved dramatically when compared to that fabricated from certain cyanine and hemicyanine dyes |
| 03/29/2007 | US20070072904 1-arylsulfone-substituted indole carboxylic acids or amides; peroxisome proliferator-activated receptor PPAR modulators; obesity, diabetes, cardiovascular disorders |
| 03/29/2007 | US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 03/29/2007 | US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
| 03/29/2007 | US20070072873 Novel thiophene derivatives which are HM74A agonists |
| 03/29/2007 | US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS |
| 03/29/2007 | US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors |
| 03/29/2007 | US20070072853 Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof |
| 03/29/2007 | US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors |
| 03/29/2007 | US20070069197 Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbzoles |
| 03/29/2007 | DE102005045518A1 New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa |
| 03/29/2007 | CA2619068A1 Imidazole compounds for the treatment of neurological disorders |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 03/28/2007 | EP1765814A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists |
| 03/28/2007 | EP1765813A1 Substituted indazoles, compositions containing same, preparation and use |
| 03/28/2007 | EP1765810A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/28/2007 | EP1765803A1 Quaternary salt ccr2 antagonists |
| 03/28/2007 | EP1765778A2 N-sulfonylcarboximidamide apoptosis promoters |
| 03/28/2007 | EP1765354A1 Leptomycin compounds |
| 03/28/2007 | CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 03/28/2007 | CN1938291A Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 03/28/2007 | CN1938283A Pyridazinones as antagonists of alpha4 integrins |
| 03/28/2007 | CN1938279A Modulators of atp-binding cassette transporters |
| 03/28/2007 | CN1938274A Novel piperidines as chemokine modulators (CCR) |
| 03/28/2007 | CN1938031A Biaryl substituted pyrazinones as sodium channel blockers |
| 03/28/2007 | CN1935808A Long-Chain aromatic piperazine modified duloxetine-like compound, and its preparation and use |
| 03/28/2007 | CN1935807A Aryl piperazine modified benzo [b] thiophene compound, and its preparing method and use |
| 03/28/2007 | CN1935797A Novel bichalcophenes and their prodrugs as antiprotozoal agents |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/27/2007 | US7196206 Asymmetrical linear organic oligomers |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196199 Phenoxypropylamine compounds |
| 03/27/2007 | US7196114 Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use |
| 03/27/2007 | US7196106 Cyanothiophene derivatives, compositions containing such compounds and methods of use |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196100 Opioid receptor antagonists |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | CA2251820C Substituted benzylamines and their use for the treatment of depression |
| 03/27/2007 | CA2208018C Sulfonamides |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007032203A1 Process for production of ortho-metallized 1:3 complex of iridium with homoligand |
| 03/22/2007 | WO2007031720A1 1,2-diarylimidazoles for use as cbi modulators |
| 03/22/2007 | WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | WO2007006926A3 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 03/22/2007 | WO2006119758A3 Dihydroxyphenylalanine derivatives |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066660 e.g. (5-chloro-6-trifluoromethyl-1H-benzimidazol-2-yl)[4-(pyridin-4-yloxy) phenyl]amine; tyrosine kinases receptor (such as TIE-2) inhibitor; anticarcinogenic, antiinflammatory agent; autoimmune diseases; rheumatoid arthritis, psoriasis, contact dermatitis, leukaemia, lung adenocarcinoma |
| 03/22/2007 | US20070066655 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists |
| 03/22/2007 | US20070066652 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 03/22/2007 | US20070066645 Novel compounds |
| 03/22/2007 | US20070066611 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide |
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066595 Selective estrogen receptor modulators |
| 03/22/2007 | US20070066587 Substituted azetidine compounds, their preparation and use as medicaments |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 03/22/2007 | US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments |
| 03/22/2007 | CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | CA2621408A1 1,2-diarylimidazoles for use as cb1 modulators |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 03/21/2007 | EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 03/21/2007 | EP1763527A1 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 03/21/2007 | EP1763524A1 Indole derivatives and use thereof as kinase inhibitors |
| 03/21/2007 | EP1763517A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 03/21/2007 | EP1763303A1 Substituted pyridazine carboxamides and derivatives thereof |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 03/21/2007 | EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
| 03/21/2007 | EP1313729B1 Design and synthesis of thiophene derived nlo materials for electro-optic applications |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
| 03/21/2007 | CN1934094A Diaryl-substituted five-membered heterocycle derivative |
| 03/21/2007 | CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/21/2007 | CN1934087A Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of T cells and/or keratinocytes |
| 03/21/2007 | CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 03/21/2007 | CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors |
| 03/21/2007 | CN1931840A DNA target molecules and their application in inducing apoptosis and antagonizing tumor |
| 03/21/2007 | CN1931839A Synthesis process of N-substituted pyrrole |